Sphera Funds Management Ltd.
- SEC CIK
- 0001496201
- Latest filing
- Aug 14, 2026
Holdings in Q3 2023
Holdings as of Sep 30, 2023, filed Nov 14, 2023. Long positions only; changes compare share counts with Q2 2023.
- Positions
- 75
- −1 vs. Q2 2023
- Portfolio value
- $416.7M
- −$49.9M (−10.7%) vs. Q2 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| SNYSanofi | SPONSORED ADR | 499,515 | $26.8M | 6.4% | −30,000−5.7% | Reduced | History |
| AZNAstraZeneca PLC | SPONSORED ADR | 285,060 | $19.3M | 4.6% | 00.0% | Unchanged | History |
| Enphase Energy, Inc.29355AAK3 | NOTE 3/0 | 20,900,000 | $17.3M | 4.2% | +6,590,000+46.1% | Added | – |
| JNJJohnson & Johnson | Stock | 94,831 | $14.8M | 3.5% | −25,000−20.9% | Reduced | History |
| MRKMerck & Co., Inc. | Stock | 123,600 | $12.7M | 3.1% | +3,000+2.5% | Added | History |
| AMZNAmazon Com Inc | Stock | 95,300 | $12.1M | 2.9% | −29,000−23.3% | Reduced | History |
| TSEMTower Semiconductor Ltd | SHS NEW | 469,574 | $11.5M | 2.8% | +302,128+180.4% | Added | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 773,061 | $11.2M | 2.7% | +50,000+6.9% | Added | History |
| MSFTMicrosoft Corp | Stock | 34,442 | $10.9M | 2.6% | +130+0.4% | Added | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 259,135 | $9.24M | 2.2% | +75,439+41.1% | Added | History |
| BBIOBridgeBio Pharma, Inc. | COM | 345,537 | $9.11M | 2.2% | +23,902+7.4% | Added | History |
| NVONovo Nordisk A S | ADR | 93,080 | $8.46M | 2.0% | −20,000−17.7% | ReducedConverted for a 2-for-1 split | History |
| PRAXPraxis Precision Medicines, Inc. | COM | 4,850,317 | $8.29M | 2.0% | −3,914,017−44.7% | Reduced | History |
| LLYEli Lilly & Co | Stock | 14,190 | $7.62M | 1.8% | −1,500−9.6% | Reduced | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 50,867 | $7.43M | 1.8% | +25,867+103.5% | Added | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 319,911 | $7.40M | 1.8% | +7,286+2.3% | Added | History |
| IMTXImmatics N.V. | SHS | 617,173 | $7.15M | 1.7% | 00.0% | Unchanged | History |
| SHL Telemedicine Ltd78423T200 | ADS | 632,256 | $6.96M | 1.7% | −82,317−11.5% | Reduced | – |
| CYTKCytokinetics Inc | COM NEW | 233,933 | $6.89M | 1.7% | +233,933 | New | History |
| ABBVAbbVie Inc. | Stock | 46,000 | $6.86M | 1.6% | −10,000−17.9% | Reduced | History |
| PANWPalo Alto Networks Inc | Stock | 28,759 | $6.74M | 1.6% | +1,759+6.5% | Added | History |
| BIIBBiogen Inc. | COM | 25,846 | $6.64M | 1.6% | +2,000+8.4% | Added | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 530,000 | $6.50M | 1.6% | 00.0% | Unchanged | History |
| KURAKura Oncology, Inc. | COM | 703,287 | $6.41M | 1.5% | +100,000+16.6% | Added | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 36,101 | $6.39M | 1.5% | −3,899−9.7% | Reduced | History |
| NICENICE Ltd. | SPONSORED ADR | 37,482 | $6.37M | 1.5% | −50,000−57.2% | Reduced | History |
| PNTPOINT Biopharma Global Inc. | COM | 952,642 | $6.35M | 1.5% | 00.0% | Unchanged | History |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 600,000 | $6.12M | 1.5% | −450,000−42.9% | Reduced | History |
| NVSNovartis AG | ADR | 60,000 | $6.11M | 1.5% | 00.0% | Unchanged | History |
| SRPTSarepta Therapeutics, Inc. | COM | 50,000 | $6.06M | 1.5% | 00.0% | Unchanged | History |
| MRUSMerus N.V. | COM | 253,333 | $5.97M | 1.4% | −25,000−9.0% | Reduced | History |
| IRONDisc Medicine, Inc. | COM | 111,398 | $5.23M | 1.3% | −59,180−34.7% | Reduced | History |
| INZYInozyme Pharma, Inc. | COM | 1,234,907 | $5.19M | 1.2% | +102,940+9.1% | Added | History |
| AMDAdvanced Micro Devices Inc | Stock | 48,320 | $4.97M | 1.2% | +48,320 | New | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 180,000 | $4.95M | 1.2% | +20,000+12.5% | Added | History |
| ETNB89bio, Inc. | COM | 319,301 | $4.93M | 1.2% | +184,301+136.5% | Added | History |
| PTCTPTC Therapeutics, Inc. | COM | 218,459 | $4.90M | 1.2% | +118,359+118.2% | Added | History |
| INBXInhibrx Biosciences, Inc. | COM | 256,371 | $4.70M | 1.1% | +206,371+412.7% | Added | History |
| METAMeta Platforms, Inc. | Stock | 15,220 | $4.57M | 1.1% | +15,220 | New | History |
| Gracell Biotechnologies Inc38406L103 | SPONSORED ADS | 1,531,497 | $4.41M | 1.1% | +302,832+24.6% | Added | – |
| ATXSAstria Therapeutics, Inc. | COM | 580,599 | $4.33M | 1.0% | +109,581+23.3% | Added | History |
| MLYSMineralys Therapeutics, Inc. | COM | 455,400 | $4.33M | 1.0% | +50,000+12.3% | Added | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 209,040 | $4.28M | 1.0% | −26,960−11.4% | Reduced | History |
| COGTCogent Biosciences, Inc. | COM | 420,000 | $4.09M | 1.0% | 00.0% | Unchanged | History |
| JSPRJasper Therapeutics, Inc. | COM | 5,687,134 | $3.98M | 1.0% | +1,413,126+33.1% | Added | History |
| PMNProMIS Neurosciences Inc. | COM | 1,834,042 | $3.69M | 0.9% | +1,834,042 | New | History |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | 50,000 | $3.65M | 0.9% | 00.0% | Unchanged | – |
| GSKGSK plc | ADR | 100,000 | $3.63M | 0.9% | 00.0% | Unchanged | History |
| MIRMMirum Pharmaceuticals, Inc. | COM | 114,284 | $3.61M | 0.9% | +114,284 | New | History |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 193,650 | $3.55M | 0.9% | +93,650+93.7% | Added | History |
| FUSNFusion Pharmaceuticals Inc. | COM | 1,354,258 | $3.52M | 0.8% | +25,000+1.9% | Added | History |
| REPLReplimune Group, Inc. | COM | 185,016 | $3.17M | 0.8% | +185,016 | New | History |
| GILDGilead Sciences, Inc. | Stock | 40,000 | $3.00M | 0.7% | 00.0% | Unchanged | History |
| PFEPfizer Inc | Stock | 90,000 | $2.99M | 0.7% | −50,000−35.7% | Reduced | History |
| PLRXPliant Therapeutics, Inc. | COM | 156,134 | $2.71M | 0.6% | +156,134 | New | History |
| ICLICL Group Ltd. | SHS | 470,000 | $2.61M | 0.6% | +470,000 | New | History |
| CRWDCrowdStrike Holdings, Inc. | Stock | 15,000 | $2.51M | 0.6% | +15,000 | New | History |
| KZRKezar Life Sciences, Inc. | COM | 2,051,676 | $2.44M | 0.6% | +63,448+3.2% | Added | History |
| MORFMorphic Holding, Inc. | COM | 90,000 | $2.06M | 0.5% | 00.0% | Unchanged | History |
| ALPNAlpine Immune Sciences, Inc. | COM | 180,000 | $2.06M | 0.5% | −20,000−10.0% | Reduced | History |
| GOSSGossamer Bio, Inc. | COM | 1,932,568 | $1.61M | 0.4% | +1,932,568 | New | History |
| VERAVera Therapeutics, Inc. | CL A | 105,000 | $1.44M | 0.3% | 00.0% | Unchanged | History |
| HOWLWerewolf Therapeutics, Inc. | COM | 626,810 | $1.34M | 0.3% | 00.0% | Unchanged | History |
| XENEXenon Pharmaceuticals Inc. | COM | 38,959 | $1.33M | 0.3% | +38,959 | New | History |
| RIGLRigel Pharmaceuticals Inc | COM NEW | 1,228,126 | $1.33M | 0.3% | 00.0% | Unchanged | History |
| RZLTRezolute, Inc. | COM NEW | 996,710 | $1.32M | 0.3% | −159,187−13.8% | Reduced | History |
| CGENCompugen Ltd | ORD | 1,319,239 | $1.23M | 0.3% | +89,431+7.3% | Added | History |
| MDWDMediWound Ltd. | SHS NEW | 108,533 | $1.15M | 0.3% | −2,594−2.3% | Reduced | History |
| QUREuniQure N.V. | SHS | 148,734 | $998.0K | 0.2% | 00.0% | Unchanged | History |
| RNACCartesian Therapeutics, Inc. | COM | 752,137 | $797.3K | 0.2% | −1,286,363−63.1% | Reduced | History |
| APGEApogee Therapeutics, Inc. | COM | 30,000 | $639.0K | 0.2% | +30,000 | New | History |
| ELEVElevation Acquisition Group Inc. | COM | 900,000 | $596.3K | 0.1% | 00.0% | Unchanged | History |
| VTGNVistagen Therapeutics, Inc. | COM | 100,000 | $524.0K | 0.1% | +100,000 | New | History |
| Immatics N.V.N44445117 | *W EXP 07/01/202 | 100,000 | $354.0K | 0.1% | 00.0% | Unchanged | – |
| Calliditas Therapeutics AB13124Q106 | SPONSERED ADS | 11,863 | $216.6K | 0.1% | +11,863 | New | – |
Options (7)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | – | $51.1M |
| Invesco QQQ Tr46090E953 | PUT | $48.9M | – |
| NICENICE Ltd. | SPONSORED ADR | – | $17.9M |
| SEDGSolaredge Technologies, Inc. | COM | – | $6.93M |
| XENEXenon Pharmaceuticals Inc. | COM | $2.81M | – |
| CLDXCelldex Therapeutics, Inc. | COM NEW | – | $2.75M |
| CYTKCytokinetics Inc | COM NEW | – | $1.91M |
Sold out since Q2 2023 (15)
Positions held at the end of Q2 2023 that are gone from this filing.
| Security | Class | Shares in Q2 2023 | Value in Q2 2023 | % of portfolio in Q2 2023 | History |
|---|---|---|---|---|---|
| NVMINova Ltd. | COM | 70,000 | $8.21M | 1.8% | History |
| CAMTCamtek Ltd | ORD | 189,494 | $6.75M | 1.4% | History |
| SAGESage Therapeutics, Inc. | COM | 128,000 | $6.02M | 1.3% | History |
| ISEEIVERIC bio, Inc. | COM | 134,414 | $5.29M | 1.1% | History |
| QCOMQualcomm Inc | Stock | 32,000 | $3.81M | 0.8% | History |
| ENLTEnlight Renewable Energy Ltd. | SHS | 211,586 | $3.76M | 0.8% | History |
| TVTXTravere Therapeutics, Inc. | COM | 213,462 | $3.28M | 0.7% | History |
| ACLXArcellx, Inc. | COMMON STOCK | 77,488 | $2.45M | 0.5% | History |
| ALTAltimmune, Inc. | COM NEW | 500,000 | $1.76M | 0.4% | History |
| MRSNMersana Therapeutics, Inc. | COM | 418,562 | $1.38M | 0.3% | History |
| DYNDyne Therapeutics, Inc. | COM | 119,918 | $1.35M | 0.3% | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 187,800 | $1.18M | 0.3% | History |
| INFIInfinity Pharmaceuticals, Inc. | COM | 1,476,000 | $310.7K | 0.1% | History |
| Bio Green Med Solution, Inc.23254L603 | COM | 250,000 | $147.3K | <0.1% | – |
| ARBEArbe Robotics Ltd. | COM | 43,165 | $124.7K | <0.1% | History |